Treatment With Brentuximab Vedotin Plus Bendamustine in Unselected Patients With CD30-positive Aggressive Lymphomas 24. September 2020 24. September 2020 Share EmailTwitterFacebookGoogle +PinterestTumblrLinkedinVkontakte